Ara
Toplam kayıt 9, listelenen: 1-9
Could the systemic immune-inflammation index be a predictor to estimate cerebrovascular events in hypertensive patients?
(Lippincott Williams & Wilkins, 2022)
Background and objectives Hypertension is one of the most important risk factors for cardiovascular and cerebrovascular events. Inflammatory processes occupy an important place in the pathogenesis of hypertension. Many ...
Author's Reply [2020]
(Turkish Society of Cardiology, 2020)
[No abstract available]
Measurement of salusin-beta without the addition of NP-40 or Tween-20 in coronary slow-flow phenomenon Reply
(Aves, 2020)
[No Abstract Available]
Salusin beta, atherosclerosis, and coronary slow flow Reply
(Turkish Soc Cardiology, 2020)
[No Abstract Available]
Author`s reply
(Turkish Society of Cardiology, 2020)
[No abstract available]
Exercise and Coronary Heart Disease
(Springer-Verlag Singapore Pte Ltd, 2020)
Coronary artery disease (CAD) can be obstructive or nonobstructive. Patients with nonobstructive and stable angina pectoris are usually women. Nonobstructive CAD is caused by endothelial dysfunction at the microvascular ...
Exercise and Hypertension
(Springer-Verlag Singapore Pte Ltd, 2020)
Hypertension is a fatal yet preventable risk factor for cardiovascular disease and is responsible for majority of cardiovascular mortality. Hypertension is closely associated with inactive lifestyle. Physical activity ...
The relationship between nondipper hypertension and triglyceride glucose index
(Lippincott Williams & Wilkins, 2022)
Nondipper hypertensive patients have an increased incidence of damage to end organs, including the brain, heart, and kidney, and a worse cardiovascular prognosis. The triglyceride glucose (TyG) index is a reliable indicator ...
Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure
(Limited Liability Company KlinMed Consulting, 2023)
Aim The primary objective of this study was to comparatively assess the effects of levosimendan and dobutamine on RVEF, right ventricular diastolic function, and hormonal balance in patients with biventricular heart failure. ...